Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease

被引：11
|
作者：
Moghavem, Nuriel [1 ]
Henderson, Victor W. [2 ,3 ]
Greicius, Michael D. [4 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90007 USA
[2] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷 / 03期
关键词：
POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1002/ana.26167
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：331 / 333
页数：3
相关论文
共 50 条
  • [21] The effectiveness and value of aducanumab for Alzheimer's disease
    Synnott, Patricia G.
    Whittington, Melanie D.
    Lin, Grace A.
    Rind, David M.
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 25 (11): : 1613 - 1617
  • [22] Aducanumab for Alzheimer's disease: Observations and opportunities
    Pridmore, William
    AUSTRALASIAN PSYCHIATRY, 2022, 30 (05) : 598 - 600
  • [23] Aducanumab for Alzheimer's disease: A regulatory perspective
    Nistico, Robert
    Borg, John Joseph
    PHARMACOLOGICAL RESEARCH, 2021, 171
  • [24] Should Canadian patients look forward to aducanumab for Alzheimer disease? Comment
    Watt, Jennifer A.
    Marple, Roger
    Hemmelgarn, Brenda
    Straus, Sharon E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (36) : E1430 - E1431
  • [25] A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease
    Mukhopadhyay, Sanchari
    Banerjee, Debanjan
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (04) : 1537 - 1552
  • [26] Aducanumab Anti-β-amyloid monoclonal antibody Treatment of Alzheimer's disease
    Khanna, G.
    Bhandari, R.
    Kuhad, A.
    Kuhada, A.
    DRUGS OF THE FUTURE, 2019, 44 (02) : 115 - 121
  • [27] Aducanumab as a Novel Treatment for Alzheimer's Disease: A Decade of Hope, Controversies, and the Future
    Esang, Michael
    Gupta, Mayank
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [28] Treatment interval dependent effects of aducanumab therapy on Alzheimer's disease neuropathology
    Patel, S.
    Lopresti, B.
    Lingler, J.
    Lopez, O.
    Kofler, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 489 - 490
  • [29] The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease
    Steinbrook, Robert
    JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1281 - 1281
  • [30] Say "ADU" to Alzheimer's: The Role of Aducanumab in Treating Alzheimer's Disease
    Lane, Jim
    Daniels, Ella
    McKusick, Alexa
    Burge, Caroline
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S773 - S773
12345